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Introduction {#s1}
============

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a robust approach for the rapid identification of microorganisms. The identification mechanism is based on the protein MS pattern obtained by MALDI-TOF MS matching microbial sequence data in available databases, the so-called fingerprinting method. This method has been rapidly developed and expanded, and has been successfully applied to the clinical field because it offers a stable, rapid and cost-effective system for microbial identification.

In using MALDI-TOF MS for the identification of microorganisms, the majority of the high-intensity MS peaks detected is derived from ribosomal proteins encoded in the *S10-spc-alpha* operon, where at least half of the ribosomal subunit proteins are encoded. This operon is highly conserved among eubacterial genomes [@pone.0113458-Watanabe1]--[@pone.0113458-BarloyHubler1]. These peaks can be reliable biomarkers with which to discriminate bacteria at a strain or pathovar level because strain-specific peaks can be predicted and verified from the DNA sequence information before measurement [@pone.0113458-Teramoto1], [@pone.0113458-Tamura1]. This methodology, known as the '*S10*-GERMS (*S10-spc-alpha* operon gene-encoded ribosomal protein mass spectrum) method', offers theoretically calculated *m/z* ion peaks of ribosomal proteins that are species- or strain-specific. An accurate database can then be constructed by comparing the experimentally observed *m/z* values with the theoretical values. The *S10*-GERMS method has been effectively employed in the identification of serovars of *Pseudomonas syringae* [@pone.0113458-Tamura1] and strains of *Lactobacillus casei* [@pone.0113458-Sato1]. Strain typing by direct bacterial profiling has increasingly been studied as a method for bacterial species identification in recent years [@pone.0113458-Josten1]--[@pone.0113458-Benagli1].

Shiga toxin-producing *Escherichia coli*, known as enterohemorrhagic *E. coli* (EHEC), causes bloody diarrhea, hemorrhagic colitis and life-threatening hemolytic-uremic syndrome. Serovar O157:H7 is the most commonly reported EHEC serovar causing many outbreaks and significantly threatening human life worldwide. Serovars O26 and O111 are also responsible for a large number of EHEC outbreaks.

Attempts to classify EHEC serovars by MALDI-TOF MS have been reported [@pone.0113458-Clark1]; however, the results are dependent on sample preparation conditions and the biomarker proteins are not assigned. To allow this method to be practically applied in the field, it needs to be versatile and reliable. In another study, *E. coli* O157:H7-specific biomarkers HdeA, HdeB, CspC, YbgS, YjbJ and YbgO were identified using MALDI-TOF/TOF-MS/MS [@pone.0113458-Fagerquist1], in which only 1 Da difference was sufficient to distinguish *E. coli* O157 from other serovars.

Here, we report the discrimination of *E. coli* O157, O26 and O111 serovars with four specific biomarker proteins based on the *S10*-GERMS method by MALDI-TOF MS. These biomarker peaks that are assigned and validated by DNA sequence analysis are detected under any of the sample conditions tested, with high reproducibility, using conventional MALDI-TOF MS analysis.

Materials and Methods {#s2}
=====================

Bacterial strains and growth conditions {#s2a}
---------------------------------------

Thirty EHEC strains, 4 shiga toxin non-producing O157 strains and 16 non-EHEC strains were used for the construction of a theoretical mass database ([Table 1](#pone-0113458-t001){ref-type="table"}). They were purchased from the National BioResource Project (NBRP; a division of pathogenic microbe, Gifu University, Gifu, Japan), the American Type Culture Collection (ATCC; Rockville, MD, USA), the Japan Collection of Microorganisms, RIKEN BRC (JCM, Tsukuba, Japan), which is participating in the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Biological Resource Center at the National Institute of Technology and Evaluation (NITE, Kisarazu, Japan). Three shiga toxin non-producing O157 (strains WT-141, WT-351 and WT-352) were kindly provided by Dr. Hiroshi Asakura (National Institute of Health Sciences, Japan). Nutrient broth (Becton Dickinson, Franklin Lakes, NJ, USA), tryptone soya agar (Thermo Scientific, Waltham, MA), or Luria--Bertani broth (Nacalai, Kyoto, Japan) were used for cultivation. For the blind test, another 57 *E. coli* strains, namely 12 *E. coli* strains (strains jfrl 01--12), that were isolated from food samples through 1996 to 2010 and identified as O157 or O26 by the antisera coagglutination test (Denka Seiken, Tokyo, Japan), and 45 *E. coli* strains that were kindly provided from Aichi Prefectural Institute of Public Health (APIPH) were used ([Table 1](#pone-0113458-t001){ref-type="table"}). The production of verotoxin in these strains was also checked by the coagglutination test (VTEC-RPLA, Denka Seiken).

10.1371/journal.pone.0113458.t001

###### *E. coli* strains used in this study.

![](pone.0113458.t001){#pone-0113458-t001-1}

  Strain                             Characteristics                      Source
  --------------- ------------------------------------------------------ --------
  GTC 03904                 O157:H7, VT--Shiga toxin negative              NBRP
  GTC 14513                            O157:H7:VT2                         NBRP
  GTC 14535                           O157:H7:VT1&2                        NBRP
  GTC 14536                           O157:H7:VT1&2                        NBRP
  GTC 14537                            O157:H7:VT2                         NBRP
  GTC 14544                           O157:H7:VT1&2                        NBRP
  GTC 14545                           O157:H7:VT1&2                        NBRP
  GTC 14546                            O157:H7:VT2                         NBRP
  GTC 14547                            O157:H7:VT2                         NBRP
  GTC 14550                            O157:H7:VT2                         NBRP
  GTC 14551                           O157:H7:VT1&2                        NBRP
  GTC 14552                           O157:H7:VT1&2                        NBRP
  GTC 14553                            O157:H7:VT2                         NBRP
  GTC 14507                           O111:H-:VT1&2                        NBRP
  GTC 14517                            O111:H-:VT1                         NBRP
  GTC 14515                           O26:H11:VT1&2                        NBRP
  GTC 14516                            O26:H11:VT1                         NBRP
  GTC 14538                             O26:H-:VT1                         NBRP
  GTC 14539                           O26:H11:VT1&2                        NBRP
  GTC 14540                            O26:H11:VT1                         NBRP
  GTC 14548                             O26:H-:VT1                         NBRP
  GTC 14549                            O26:H11:VT1                         NBRP
  GTC 14557                            O26:H11:VT1                         NBRP
  GTC 14558                            O26:H11:VT1                         NBRP
  GTC 14530                            O121:H19:VT2                        NBRP
  GTC 14601                            O121:H19:VT2                        NBRP
  GTC 14602                            O121:H19:VT2                        NBRP
  GTC 14518                            O115:H10:VT1                        NBRP
  GTC 14529                            O119:H2:VT1                         NBRP
  GTC 14559                             O63:H6:VT2                         NBRP
  GTC 14603                           O128:H-:VT1&2                        NBRP
  NBRC 12713        Genome sequenced K-12 strain. The alias of W3110.      NITE
  ATCC 47076        Genome sequenced K-12 strain. The alias of MG1655.     ATCC
  NBRC 13893                                                               NITE
  NBRC 15034                                                               NITE
  NBRC 14237                                                               NITE
  NBRC 13891                                                               NITE
  NBRC 3301                            K-12 strain.                        NITE
  NBRC 3972                                                                NITE
  NBRC 12062                                                               NITE
  NBRC 13168                                                               NITE
  NBRC 3548                                                                NITE
  NBRC 12734                                                               NITE
  JCM16574                  Genome sequenced strain, O152:H28              JCM
  ATCC BAA-1743                  Genome sequenced strain                   ATCC
  JCM16575                   Genome sequenced strain, O150:H5              JCM
  NBRC 3991                                                                NITE
  WT-141           O157: VT- Shiga toxin Negative, isolated from human   
  WT-351           O157: VT- Shiga toxin Negative, isolated from cattle  
  WT-352           O157: VT- Shiga toxin Negative, isolated from cattle  
  jfrl 01                O157:H7:VT2, isolated from pork in 1998         
  jfrl 02                O157:H7:VT2, isolated from beef in 1996         
  jfrl 03               O157:H7:VT1&2, isolated from beef in 1998        
  jfrl 04               O157:H7:VT1&2, isolated from beef in 1996        
  jfrl 05             O157:H7:VT2, isolated from welsh onion in 1996     
  jfrl 06                 O157:VT1&2, isolated from beef in 2003         
  jfrl 07                 O157:VT 2, isolated from beef in 1999          
  jfrl 08                O157: VT1&2, isolated from beef in 1999         
  jfrl 09                  O157:VT2, isolated from beef in 2010          
  jfrl 10                  O157:VT2, isolated from beef in 2010          
  jfrl 11                  O157:VT2, isolated from beef in 2010          
  jfrl 12                  O26, VT1, isolated from beef in 2010          
  A11-1                               O157:H7, VT1&2                      APIPH
  A11-85                             O157:HUT, VT1&2                      APIPH
  A11-87                              O157:H7, VT1&2                      APIPH
  A11-88                              O157:H7, VT1&2                      APIPH
  A11-89                              O157:H7, VT1&2                      APIPH
  A11-90                              O157:H7, VT1&2                      APIPH
  A11-161                              O157:H7, VT2                       APIPH
  A11-163                              O157:H7, VT2                       APIPH
  A11-168                              O157:H7, VT1                       APIPH
  A11-169                             O157:H7, VT1&2                      APIPH
  A11-175                              O157:H7, VT1                       APIPH
  A11-176                              O157:H7, VT1                       APIPH
  A11-177                              O157:H7, VT1                       APIPH
  A11-225                              O157:H7, VT2                       APIPH
  A11-234                              O157:H7, VT2                       APIPH
  A12-154                              O157:H7, VT2                       APIPH
  A12-163                             O157:H7, VT1&2                      APIPH
  A12-164                              O157:H7, VT2                       APIPH
  A12-166                             O157:H7, VT1&2                      APIPH
  A12-167                             O157:H7, VT1&2                      APIPH
  A12-183                              O157:H7, VT2                       APIPH
  A12-185                            O157:HUT, VT1&2                      APIPH
  A12-190                             O157:H7, VT1&2                      APIPH
  A12-191                            O157:HUT, VT1&2                      APIPH
  A12-193                            O157:HUT, VT1&2                      APIPH
  A12-201                              O157:H7, VT2                       APIPH
  A12-209                              O157:H7, VT2                       APIPH
  A12-212                             O157:H7, VT1&2                      APIPH
  A12-222                              O157:H7, VT2                       APIPH
  A12-223                              O157:H7, VT2                       APIPH
  A12-97                               O26:H11, VT1                       APIPH
  A12-98                               O26:H11, VT1                       APIPH
  A12-99                               O26:H11, VT1                       APIPH
  A12-100                              O26:H11, VT1                       APIPH
  A12-147                              O26:H11, VT1                       APIPH
  A13-137                              O26:H11, VT1                       APIPH
  A13-138                              O26:H11, VT1                       APIPH
  A13-154                              O26:H11, VT2                       APIPH
  A13-155                              O26:H11, VT2                       APIPH
  A13-165                              O26:H11, VT1                       APIPH
  A12-152                             O111:HUT, VT1                       APIPH
  A12-161                             O111:H21, VT1                       APIPH
  A12-162                            O111:H21, VT1&2                      APIPH
  A12-200                             O111:HUT, VT1                       APIPH
  A12-216                             O121:H19, VT2                       APIPH

Construction of the protein mass database {#s2b}
-----------------------------------------

The amino acid sequences of ribosomal subunit proteins and biomarker candidates of genome sequenced strains were obtained from the National Center for Biotechnology Information (NCBI) database. The theoretical ionized mass of each protein was calculated using a Compute pI/Mw tool on the ExPASy proteomics server (<http://web.expasy.org/compute_pi/>), considering the N-terminal rule. For the non-genome-sequenced strains, the DNA sequence of the ribosomal proteins encoded in the *S10-spc-alpha* operon and biomarker candidates were analyzed as described previously [@pone.0113458-Hotta1]. In brief, respective regions of ribosomal protein-encoding genes (≈5 kbp) or genes encoding biomarker proteins were amplified using high-fidelity DNA polymerase, KOD plus (Toyobo, Osaka, Japan), and primers designed against the consensus DNA sequences up- and down-stream of the target regions in the *E. coli* genome sequences in the NCBI database. Sequencing reactions were carried out using a BigDye ver. 3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). DNA primers used for PCR and sequence analysis are listed in [Table 2](#pone-0113458-t002){ref-type="table"}.

10.1371/journal.pone.0113458.t002

###### Primers used in this study.

![](pone.0113458.t002){#pone-0113458-t002-2}

  Name                  Sequence (5′ -- 3′)                    Purpose
  ------------------ -------------------------- --------------------------------------
  EcW3110-S10-F         AAGAACGGTTACACTCTCCC        amplification of *S10* region
  EcW3110-S10-R         ACACCGCTTCAAGGATATGG        amplification of *S10* region
  EcW3110-S10-1        AATCGTAATGGGTCTGAGGAG                  sequencing
  EcW3110-S10-2        AAGCTGGCCACTTCGCTAAAG                  sequencing
  EcW3110-S10-3        TGCTGAAGTAACTGGTTCCGG                  sequencing
  EcW3110-S10-4         AAGCTGCTGTGCAGAAACTG                  sequencing
  EcW3110-S10-5       CATAACGTAGAAATGAAACCAGG                 sequencing
  EcW3110-S10-6        ACGTTCCGGTATTTGTAACCG                  sequencing
  EcW3110-S10-7         TCAGTACCTGACTAAGGAAC                  sequencing
  EcW3110-S10-8         AGCGTCGCTGATGTTACAAC                  sequencing
  EcW3110-S10-9        AGCAAGTGCGTCGCGATGTCG                  sequencing
  EcW3110-S10-10      GCTGGCATGATTCGTGAAGAACG                 sequencing
  EcW3110-spc-F         AACGGCTCAGAAATGAGCCG        amplification of *spc* region
  EcW3110-spc-R         AGCAGTCTGCGTTTCAGCTC        amplification of *spc* region
  EcW3110-spc-1         TCTACCCATATCCTTGAAGC                  sequencing
  EcW3110-spc-2        ATTGTTGAAGGTATCAACCTG                  sequencing
  EcW3110-spc-3         TCGTGGTAACTACAGCATG                   sequencing
  EcW3110-spc-4         ACCATGCCTTCCTCCAAGCT                  sequencing
  EcW3110-spc-5        TTGGTGTAGGTTACCGTGCAG                  sequencing
  EcW3110-spc-6         ATGCTGCCCGTGAAGCTGGC                  sequencing
  EcW3110-spc-7        ATCGGTCGTCTGCCGAAACAC                  sequencing
  EcW3110-spc-9        GTCACCATGCCTTCCTCCAAG                  sequencing
  EcW3110-spc-1r       GATGATGTCGCCTACGCCTGC                  sequencing
  EcW3110-spc-2r        TTACCGGTTAACACGATAAC                  sequencing
  EcW3110-alpha-F      AGTGCCAAAGGTGGCTTAGGC       amplification of *alpha* region
  EcW3110-alpha-R      ACAGCTATTGTAGATAAGTGG       amplification of *alpha* region
  EcW3110-alpha-1      TGCCCATACTATCGAGCAAGC                  sequencing
  EcW3110-alpha-2      TCACTGCTTATCGTTGTTGTC                  sequencing
  EcW3110-alpha-3      TGTCGTTGAAGGTGATCTGCG                  sequencing
  EcW3110-alpha-4       AATGGCAAGATATTTGGGTC                  sequencing
  EcW3110-alpha-5      TGCGGACATTAACGAACACCTG                 sequencing
  EcW3110-alpha-6      TGCCTACAATGTTGAAGCAGCG                 sequencing
  EcW3110-alpha-7      AGCTGCGCCGCGTAGTTGAGC                  sequencing
  EcW3110-alpha-1r      AGCTGGATAATGATCGACGC                  sequencing
  EcW3110-L25-F        TTCGAGCAGCTTTTTATCCGCC            amplification of L25
  EcW3110-L25-R       AAGGCTACGAACTGGAAGAGAGC            amplification of L25
  EcW3110-L25-1         ATACGCGCACACCGGGCATC                  sequencing
  EcW3110-L25-1r       AGACCGTAGCACACTGCGTCAG                 sequencing
  EcW3110-S15-F       TACGAACGATCGGATTAAGCAATG           amplification of S15
  EcW3110-S15-R       TTACTTGATCCATTACTGATGCC            amplification of S15
  EcW3110-S15-1        GGATTAAGCAATGTAATATCC                  sequencing
  EcW3110-S15-1r      ATTACTGATGCCAATGGACAGTCC                sequencing
  Ec_HdeB-F            GATATGTAATTCCGGGAATGC     amplification and sequencing of HdeB
  Ec_HdeB-R           AAGGAGCAGCAAGATGGCTCAAC           amplification of HdeB
  Ec_YdaQ-F            TCATAGCTGATTATTAATAATC           amplification of YdaQ
  Ec_YdaQ-R            ATGAACCAGATGCGAATGTAT            amplification of YdaQ
  Ec_HNS-F             TGAATTCCTTACATTCCTGGC     amplification and sequencing of H-NS
  Ec_HNS-R             AGCTTATTCTTATTAAATTGTC           amplification of H-NS

MALDI-TOF MS analysis for the evaluation of the mass database {#s2c}
-------------------------------------------------------------

Bacterial colonies grown on agar plate were picked and placed directly onto a measurement steel plate, while bacteria from liquid culture were harvested by centrifugation then washed with TMA-I buffer (10 mM Tris-HCl pH 7.8, 30 mM NH~4~Cl, 10 mM MgCl~2~ and 6 mM 2-mercaptoethnol). Approximately 10^7^ cfu were mixed well with 1 µL of matrix solution consisting of 20 mg/mL sinapic acid (Wako Pure Chemical) or saturated α-cyano-4-hydroxycinnamic acid (CHCA), and 1% (v/v) trifluoroacetic acid (Wako Pure Chemical) in 50% (v/v) acetonitrile. The mixture was spotted onto the MALDI sample plate and air dried. MALDI-TOF MS analysis was performed using an AXIMA micro-organism identification (Shimadzu/Kratos, Kyoto, Japan) as described previously, with minor modifications [@pone.0113458-Tamura1]. Briefly, the sample was measured in the positive linear mode in the spectrum range of *m*/*z* 2000--20000. Data were obtained from the sum of 100 individual laser shots and calibrated with the *E. coli* strain DH5α using the peaks at *m/z* 4365.4, 7274.5, 10300.1, 12770.6 and 14365.6, corresponding to ribosomal proteins L36, L29, S19, L18 and L17, respectively. After calibrating manually, each sample was automatically calibrated with the same internal peaks as DH5α. Theoretical and measured masses were matched with 500 ppm tolerance. The actual masses in the MALDI-TOF MS spectra were matched with the theoretical values and corrected appropriately.

Automated MALDI-TOF MS analysis for validation {#s2d}
----------------------------------------------

Samples prepared from colonies were automatically analyzed to verify the effectiveness and reproducibility of selected biomarkers. Four analytes per strain were prepared as described above. To evaluate the effects of culture medium on the masses of selected biomarkers, typical selective media for *Enterobacteriaceae* or O157, desoxycholate agar (Nissui Pharmaceutical, Tokyo, Japan), CT-SMAC (Kyokuto Pharmaceutical Industrial, Tokyo, Japan), Chromagar X-gal (Chromagar, Paris, France), and crystal violet neutral red bile lactose agar (VRBL, Thermo scientific) were tested in addition to the normal growth media such as nutrient broth, tryptone soya agar or Luria--Bertani broth.

Cluster analysis {#s2e}
----------------

Fingerprints of protein mass patterns were analyzed with SARAMIS (Spectral Archive and Microbial Identification System, AnagnosTec, Postdam-Golm, Germany) to construct binary matrices of biomarkers. The data were imported into the PAST software (<http://folk.uio.no/ohammer/past/>, Natural History Museum, Oslo University, Norway) to calculate distance matrices using the neighbor-joining method with Kimura algorithm. A phylogenetic tree was constructed using the FigTree ver. 1.4.0 software (<http://tree.bio.ed.ac.uk/software/figtree/>) as described previously [@pone.0113458-Ziegler1].

Blind test using isolated wile-type *E. coli* strains {#s2f}
-----------------------------------------------------

To evaluate the discrimination method using our selected biomarkers, 57 *E. coli* strains, individually isolated from food (such as beef, pork and Welsh onions) or humans and identified as serovars O157, O26, O111 or O121 by antisera testing, were analyzed by MALDI-TOF MS. Semi-automated classification was demonstrated according to the mass patterns of selected four biomarker proteins.

Nucleotide sequence accession numbers {#s2g}
-------------------------------------

The nucleotide sequences of ribosomal proteins encoded in the *S10-spc-alpha* operon, biomarker proteins S15 and L25, acid stress chaperon HdeB and DNA-binding protein H-NS, of *E. coli* strains determined in this study were deposited in the DNA data bank of Japan (DDBJ, <http://www.ddbj.nig.ac.jp>) with accession numbers from AB903039 to AB903902 and AB915955 to AB916334.

Results and Discussion {#s3}
======================

Construction of the protein mass database {#s3a}
-----------------------------------------

In this study we have attempted to employ the *S10*-GERMS method for the discrimination of major serovars of EHEC O157, O26 and O111 from the others. The theoretical masses of ribosomal proteins encoded by the *S10-spc-alpha* operon were calculated based on the sequence analysis and genome sequence information ([Table 3](#pone-0113458-t003){ref-type="table"}). The mass values were compared with the actual analytical results of MALDI-TOF MS and manually validated. The masses of the *S10-spc-alpha* operon-encoded ribosomal proteins not shown in [Table 3](#pone-0113458-t003){ref-type="table"}, namely S10, L3, L4, L23, L2, S19, L22, S3, L16, L29, S17, L14, L5, S14, S8, L6, L18, S5, L30, L36, S13, S11, S4 and L17, were all identical respectively in all of the *E. coli* strains used for database construction. Whereas, L24, S5 and S13, thought to be biomarker candidates from their calculated masses, gave unclear peaks because of small differences in masses or high molecular weights ([Table 3](#pone-0113458-t003){ref-type="table"}). The *S10*-GERMS method has successfully been employed for *Pseudomonas* sp., *Bacillus* sp. and *Lactobacillus* sp. in previous studies [@pone.0113458-Tamura1], [@pone.0113458-Sato1], [@pone.0113458-Hotta1], [@pone.0113458-Hotta2]. However, in the case of *E. coli*, strain or serovar typing using ribosomal proteins encoded in the *S10-spc-alpha* operon appears to be more challenging due to a less diversity of the masses. Although the ribosomal proteins encoded in the *S10-spc-alpha* operon were not suitable as biomarkers for serovars O157, O26 and O111, the other strains which are classified into group G to P in [Table 1](#pone-0113458-t001){ref-type="table"} show unique mass patterns of ribosomal proteins in the operon. It helps the strain level discrimination of *E. coli* using these biomarkers.

10.1371/journal.pone.0113458.t003

###### Theoretical masses of selected biomarker proteins for *E. coli* discrimination.
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                            Group of mass pattern                                                                                                                                                                      
  --------- -------------- ----------------------- ------------- --------- ------------- ------------- --------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Protein    Coded operon           O157               O157        O157      O26 O111         O26       O121, O128, O152, -    O115      O119       O63       K12       \-        \-        \-        \-        \-       O150
  L23            S10               11200.1            11200.1     11200.1     11200.1       11200.1           11200.1         11147.1   11200.1   11200.1   11200.1   11200.1   11200.1   11200.1   11200.1   11200.1   11200.1
  L24            spc               11186.0            11186.0     11186.0     11186.0       11186.0           11186.0         11186.0   11186.0   11216.0   11186.0   11186.0   11216.0   11186.0   11186.0   11186.0   11216.0
  S14            spc               11450.3            11450.3     11450.3     11450.3       11450.3           11450.3         11450.3   11450.3   11450.3   11450.3   11450.3   11450.3   11450.3   11464.3   11450.3   11450.3
  L15            spc               14967.4            14967.4     14967.4     14967.4       14967.4           14967.4         14981.4   14945.0   14967.4   14981.4   14981.4   14967.4   14981.4   14967.4   14967.4   14967.4
  S11+Me        alpha              13728.8            13728.8     13728.8     13728.8       13728.8           13728.8         13728.8   13728.8   13728.8   13728.8   13728.8   13728.8   13728.8   13728.8   13728.8   13756.8
  YdaQ                             8325.6               \-        8325.6      8325.6          \-              8325.6          8325.6    8325.6    8325.6    8325.6    8325.6      \-        \-      8325.6      \-        \-
  S15                            **10166.6**        **10166.6**   10138.6     10138.6       10138.6           10138.6         10138.6   10138.6   10138.6   10138.6   10137.6   10138.6   10138.6   10138.6   10138.6   10138.6
  L25                            **10676.4**        **10676.4**   10694.4     10694.4       10694.4           10694.4         10694.4   10694.4   10693.5   10694.4   10694.4   10693.5   10694.4   10694.4   10693.5   10693.5
  HdeB                               \-                 \-          \-        9066.2        9066.2            9066.2          9066.2    9066.2    9066.2    9066.2    9066.2    9066.2    9066.2    9066.2    9066.2    9066.2
  H-NS                             15409.4            15409.4     15409.4   **15425.4**   **15425.4**         15409.4         15409.4   15409.4   15409.4   15409.4   15882.0   15409.4   15409.4   15409.4   15409.4   15409.4

Theoretical mass values (*m*/*z* \[M+H\]^+^) of possible biomarkers for discrimination of *E. coli* strains are shown. The database was constructed by validated *E. coli* strains available on public collections and three isolated strains. Groups A to P indicate the classification based on mass patterns. -- in the group column indicates the O-antigen is not determined. -- in MS column means the peaks are absent.

E. coli strains belong to the groups A to P are as bellows; A: O157-351, GTC 14545, GTC 14546, GTC 14552, O157-141, GTC 14513, GTC 14535, GTC 14536, GTC 14537, GTC 14544, GTC 14547, GTC 14551 and GTC 03904; B: O157-352; C: GTC 14550 and GTC 14553; D: GTC 14517, GTC 14507, GTC 14516, GTC 14538, GTC 14540, GTC 14549, GTC 14557 and GTC 14558; E: GTC 14515, GTC 14539 and GTC14548; F: GTC 14530, GTC 14601, GTC 14602, GTC 14603, JCM16574, NBRC 12062, NBRC 13168, NBRC 12734 and NBRC 3991; G: GTC 14518; H: GTC 14529; I: GTC 14559; J: NBRC 12713, ATCC 47076, NBRC 3301, NBRC 3972; K: NBRC 13893; L: NBRC 15034 and NBRC 14237; M: NBRC 13891; N: NBRC 3548; O: ATCC BAA-1743; P: JCM 16575.

Otherwise, unique and clear mass shifts of the ribosomal proteins S15 and L25 were observed specific in *E. coli* O157 compared with the other *E. coli* serovars ([Fig. 1](#pone-0113458-g001){ref-type="fig"}, [Table 3](#pone-0113458-t003){ref-type="table"}). Sequence analysis revealed that a point mutation, A239G, on ribosomal protein S15 caused an amino acid residue change, Q80R, resulting in a MS shift of *m/z* 10138.6 to 10166.6. Similarly, the O157-specific mutation G150A in the gene encoding L25, resulting in an amino acid substitution, M50I, led to a mass shift of *m/z* 10694.4 to 10676.4. These two ribosomal proteins also showed mass shifts in the theoretical masses of *E. coli* strains GTC 14559, NBRC 15034, NBRC 14237, ATCC BAA-1743 and JCM16575 (group K, L, O and P in [Table 3](#pone-0113458-t003){ref-type="table"}), although the differences were too small to distinguish in actual MALDI-TOF MS analysis. Exceptionally, two *E. coli* O157 strains, GTC 14550 and GTC 14553, showed the same mass patterns as most of the other strains except for the absence of *m/z* 9066.2.

![Typical mass spectra of four biomarker proteins in *E. coli*.\
A) MALDI mass spectra of non-EHEC *E. coli* strain NBRC12713 and EHEC *E. coli* strain O157 GTC 14513. Three biomarker peaks, HdeB (*m/z* 9066.2 \[M+H\]^+^), ribosomal protein S15 (*m/z* 10138.6/10166.6 \[M+H\]^+^) and L25 (*m/z* 10676.4/10694.4 \[M+H\]^+^), measured using sinapic acid as the matrix, are shown. B) Biomarker peak of DNA binding protein H-NS (*m/z* 15409.4/15425.4 \[M+H\]^+^) for strains O26, O111 and other *E. coli*.](pone.0113458.g001){#pone-0113458-g001}

To our knowledge, this is the first report that ribosomal proteins S15 and L25, H-NS would be important biomarkers for O157 in MALDI-TOF MS analysis, a finding overlooked by others [@pone.0113458-Clark1]. The mass differences of ribosomal proteins greatly contribute to strain classification owing to their variability. The great abundance of these proteins in cells is also advantageous because their mass peaks are always detected as stable biomarkers under any analytical conditions (regardless of variables such as the method of sample preparation, the type of matrix or the MALDI system). In fact, the peak intensity and sharpness for proteins S15 and L25 in O157 serovars were sufficient to distinguish them from other *E. coli* serovars ([Fig. 1](#pone-0113458-g001){ref-type="fig"}). The same was possible using either sinapic acid or CHCA, whether the sample was a colony or a liquid extracted with formic acid (data not shown). Compared with the previously reported system that required time-consuming and complex sample preparation [@pone.0113458-Clark1], our method is more applicable for routine MALDI-TOF MS analysis because it can be performed directly from a single colony.

The mass spectrum of the acid stress chaperone HdeB in non-EHEC strains was previously reported by Fagerquist *et al* [@pone.0113458-Fagerquist1]. Likewise we identified HdeB at *m/z* 9066.2 \[M+H\]^+^ in non-EHEC strains, and a loss of this peak was observed in all O157 serovars used in this study with complete reproducibility, as reported by Carter *et al* [@pone.0113458-Carter1] ([Fig. 1](#pone-0113458-g001){ref-type="fig"}, [Table 3](#pone-0113458-t003){ref-type="table"}). Sequence analysis of the *hdeB* gene confirmed that the putative start codon, ATG, had a point mutation (ATA) in all O157 strains, while in all other *E. coli* strains of other serovars ATG was observed. This strongly supported the suggestion that this mutation correlates to the lack of the HdeB peak in O157 strains [@pone.0113458-Carter1].

The peak at *m/z* 6040 has been reported as a biomarker specifically present in O157 strains [@pone.0113458-Clark1]. However, in our study, the intensity of the peak at *m/z* 6040 was too low to be detectable and in more than half of the O157 strains used for the mass database (namely GTC 14513, GTC 14535, GTC 14536, GTC 14537, GTC 14544, GTC 14547, GTC 14551 and GTC 03904) the peak was absent (data not shown), suggesting that the presence/absence of suspicious biomarker proteins of low intensity is insufficient as a method for discrimination at the strain or serovar level.

In this study, the identification of other prevalent EHEC strains (O26 and O111) was considered. O26 and O111 strains could be distinguished from other *E. coli* strains by the peak at *m*/*z* 15409.4/15425.4 \[M+H\]^+^ ([Table 3](#pone-0113458-t003){ref-type="table"}, [Fig. 1](#pone-0113458-g001){ref-type="fig"}). From the sequence analysis, an amino acid change (A81S) in the DNA-binding protein H-NS in strains O26 and O111 was observed. A previous report had suggested that the protein corresponding to *m/z* 15409.4 \[M+H\]^+^ using K-12 strain (accession number P0ACF8) may be DNA-binding protein H-NS [@pone.0113458-Momo1]; however, this required further confirmation. In our study, we first assigned the H-NS mass peaks and corresponding DNA sequences, and identified a specific mass shift in the H-NS protein in strains O26 and O111. Using the *S10*-GERMS method, in which the theoretical masses of biomarker proteins are confirmed, a valid and reliable mass database could be provided.

An additional peak at *m/z* 8326 \[M+H\]^+^ appeared to be another potential biomarker for *E. coli* classification ([Table 3](#pone-0113458-t003){ref-type="table"}). Its mass was identical to the theoretical mass of hypothetical protein YdaQ in a TagIdent tool search (<http://web.expasy.org/tagident/>). PCR analysis of this gene was performed and a target band was detected in three out of the eight strains tested that did not show the peak at *m*/*z* 8326 (data not shown), suggesting that at least five strains may lack the *ydaQ* gene in their genome causing a loss of this peak in MALDI-TOF MS analysis. The expression level of YdaQ in the three strains possessing the corresponding gene may be low. Investigations into the identification of these biomarker proteins are now in progress.

Effects of culture media {#s3b}
------------------------

In species level discrimination by MALDI-TOF MS, growth condition often affect the expression pattern of proteins thus causes less reproducibility of mass spectra [@pone.0113458-Wieme1]. Here, colonies grown on various selective media were analyzed by MALDI-TOF MS and evaluated whether the important biomarker peaks HdeB, S15 and L25 for O157, and H-NS for O26 and O111 work well for their discrimination. As a result, ribosomal protein S15 and L25 whose mass shifts are characteristic to O157 were not affected by any growth medium in accordance with the previous report that the impact of growth conditions on ribosomal proteins were minimum [@pone.0113458-Valentine1]. Similarly the masses of DNA-binding protein H-NS were not affected by culture medium in any *E. coli* strain. On the other hand, mass intensity of HdeB in some strains of serovar O111 and O26 was decreased when grown on chromagar X-gal or VRBL, but nonetheless the peaks were enough to be detected in a default threshold. Therefore in the case of discrimination of O157, O26 and O111 from the others in colony directed MALDI-TOF MS analysis, the normal growth media and selective media such as desoxycholate agar, CT-SMAC, chromagar X-gal or VRBL will be available for the pre-selection of *E. coli*.

Cluster analysis {#s3c}
----------------

All of the strains analyzed were correctly identified as *E. coli* by SARAMIS. Cluster analysis based on the theoretical mass database of 10 biomarker proteins listed in [Table 3](#pone-0113458-t003){ref-type="table"}, in which the mass patterns were classified into groups A to P, was performed using the actually detected peaks in semi-automated MALDI-TOF MS analysis. As mentioned above, small mass shifts of around 1 Da in the S15 and L25 proteins observed in the theoretical database in group K, I, L, O and P in [Table 1](#pone-0113458-t001){ref-type="table"} were difficult to detect in actual MALDI-TOF MS analysis, and therefore differences in these proteins were not reflected in the cluster profiling summarized in [Table 4](#pone-0113458-t004){ref-type="table"}. In a phylogenetic tree illustrated based on this profiling, all the O157 strains were correctly classified into groups A, B, or C namely the 'O157 group' ([Fig. 2](#pone-0113458-g002){ref-type="fig"}). In addition, strains O26 and O111 belonged to the same cluster, groups D and E, owing to a mass difference in the peak at *m*/*z* 15425.4, which was observed at *m*/*z* 15409.4 in the other *E. coli* strains tested ([Fig. 1](#pone-0113458-g001){ref-type="fig"}). Although high molecular weight proteins over 10000 Da are less detectable in many cases in MALDI-TOF MS [@pone.0113458-Clark1], [@pone.0113458-Hotta2], they could be powerful biomarkers, as reported for *Salmonella* serovar identification [@pone.0113458-Dieckmann1]. To distinguish the small mass differences of S15 and L25 in group K, I, L, O and P from the others, MALDI-TOF MS analysis has mechanical limitation therefore MALDI-TOF/TOF-MS/MS analysis will be required to utilize such biomarkers in *E. coli*. Instead, the presence or absence of the *m*/*z* 8326 peak made it possible to apply more detailed grouping.

![Cluster analysis for *E. coli* strains with selected biomarkers.\
Phylogenetic tree according to the binary graph made by actual analysis in [Table 4](#pone-0113458-t004){ref-type="table"} is shown. A to P indicate the *E. coli* groups classified by the theoretical mass patterns of biomarker protein peaks in [Table 3](#pone-0113458-t003){ref-type="table"}.](pone.0113458.g002){#pone-0113458-g002}
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###### Peak pattern of *E. coli* strains in actual MALDI-TOF MS analysis.

![](pone.0113458.t004){#pone-0113458-t004-4}

            Group of mass pattern                                                          
  -------- ----------------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  L23                 1             1   1   1   1   1   2   1   1   1   1   1   1   1   1   1
  L24                 1             1   1   1   1   1   1   1   2   1   1   2   1   1   1   2
  S14                 1             1   1   1   1   1   1   1   1   1   1   1   1   2   1   1
  L15                 1             1   1   1   1   1   2   3   1   2   2   1   2   1   1   1
  S11+Me              1             1   1   1   1   1   1   1   1   1   1   1   1   1   1   2
  YdaQ                1             0   1   1   0   1   1   1   1   1   1   0   0   1   0   0
  S15                 2             2   1   1   1   1   1   1   1   1   1   1   1   1   1   1
  L25                 2             2   1   1   1   1   1   1   1   1   1   1   1   1   1   1
  HdeB                0             0   0   1   1   1   1   1   1   1   1   1   1   1   1   1
  H-NS                1             1   1   2   2   1   1   1   1   1   3   1   1   1   1   1

The actual mass of the peaks detected in MALDI-TOF MS has been replaced with number 1, 2 and 3 to represent the peak mass; 0 indicates no peak. Ribosomal protein S15 in group K and L25 in group I, L O and P were not distinguished from the others due to small mass differences in actual analysis with 500 ppm tolerance.

Discrimination of isolated wild-type *E. coli* strains {#s3d}
------------------------------------------------------

The discrimination method proposed in this study was verified by performing blind tests using 12 *E. coli* strains (O157 and O26) named as jfrl 01--12, and 45 wild-type strains (O157, O26, O111 and O121) kindly provided from provided from APIPH ([Table 1](#pone-0113458-t001){ref-type="table"}). Among total 41 O157 strains, all of them showed typical mass shifts of the ribosomal proteins S15 and L25 and an absence of the peak at *m/z* 9066.2 with MALDI-TOF MS analysis. The ribosomal protein L23 and L24 were eliminated from the biomarkers because their mass peaks were not clear. Nevertheless they were correctly classified into the O157 group as categorized in [Table 3](#pone-0113458-t003){ref-type="table"} and [Fig. 2](#pone-0113458-g002){ref-type="fig"}. In detail, 39 strains were classified into group A and jfrl 01 and 07 were classified into group B due to a loss of the *m/z* 8326 peak. This result indicates that the variety of mass patterns in our database may be sufficient for serovar level discrimination of wild-type O157 strains regardless of the place or date of isolation. It should be noted that among the genome or partial sequence available strains of *E. coli* O157 (total 126 strains in the NCBI database), 119 (94.4%) strains including Sakai, FRIK2000, EC4206, EC4045, EC4196, EC4076, EC4113, EC4486, EC869, EC4501, EC508, EC4024, FRIK966, EC4115, EC4401, EC4486, EC4501, TW14588, TW14359, EDL933 and EC4042, have the same theoretical mass patterns for the biomarker proteins S15 and L25 as group A, that is typical 'O157 group' in our experiments. Only 7 strains in the database, namely G5101, 493--89, H 2687, LSU-61, 2010C-4979C1 and 98--3133, show the same masses of the other *E. coli* strains as classified in group C type O157 in [Table 3](#pone-0113458-t003){ref-type="table"}. These findings suggest that a mass shift of ribosomal proteins S15 and L25 is common in most of O157 strains in the database, indicating that our discrimination approach that focuses on the mass shifts of S15 and L25 with the combination of a loss of HdeB peak, could be universally applied for O157 strain discrimination worldwide.

Similarly 11 O26 strains and 4 O111 strains for blind test were correctly classified into group E in [Table 3](#pone-0113458-t003){ref-type="table"} and [Fig. 2](#pone-0113458-g002){ref-type="fig"} due to specific masses of H-NS. Although we could not isolate another O26 and O111 samples, the sequence available O26 strains in database (strain 11368, CVM9942, CVM10026, CVM10224, CVM10021, CVM9952, CVM10030, CFSAN001629, 2010C-4347, 2010C-4788, 05-3646, 06-3464, 03-3500, 2010C-4430, 2010C-4819, 2010C-4834, 2010C-5028, 2011C-3270, 2010EL-1699, 2011C-3387, 2011C-3282, 2011C-3506, 2011C-3655, 2009C-3612, 2009C-3689, 2009C-3996, 2009C-4760, 2009C-4826, 2010C-3051, 2010C-3871, 2010C-3472, 2010C-3902, 2010C-4244 and 2009C-4747) and O111 strains (strain 11128, CVM9534, CVM9574, CVM9570, CVM9545, CVM9602, CVM9634, CVM9455, CVM9553, CFSAN001632, CFSAN001630, 2010C-4221, 2010C-3977, 2010C-4086, 08-4487, 2011C-3632, 2011C-3679, 2011C-3573, 2011C-3362, 2011C-3170, 2010C-4818, 2010C-4799, 2010C-4746, 2010C-4735, 2010C-4715, 2010C-4622, 2010C-4592, 04-3211, 03-3484, F6627, K6723, K6728, K6722, K6890, K6895, K6897, K6904, K6898, K6908, K6915, 2009C-4006, 2009C-4052, 2010C-3053, 2009EL-2169, 2009C-4126 and 2011C-3453) have the same theoretical mass values for DNA binding protein H-NS as group E, namely 'O26 and O111 group'. Therefore our findings for O26 and O111 will be also applicable for the isolates regardless of the date or place. A remaining wild-type strain, O121 was classified into group F.

To define O157, O26 and O111 from the others in a routine MALDI-TOF MS analysis in laboratory, masses of four selected biomarkers must be characteristic to these serovars. Although we have tested more than 11 different serovars in the present study for the construction of database and confirmed that at least no other serovars showed the same mass patterns as either O157, O26 or O111 in this experimental scale ([Table 1](#pone-0113458-t001){ref-type="table"}, [Table 3](#pone-0113458-t003){ref-type="table"}) and the biomarkers were effective in the blind test using 57 wild-type strains including O121, the examination with wider variety of serovars is desired. Since it was difficult to obtain *E. coli* strains with various serovars, the probability of our database was validated *in silico* by checking the theoretical masses of biomarkers in various types of *E. coli* serovars. Out of more than thousands of *E. coli* strains available in the NCBI database, the theoretical masses of ribosomal protein S15 and L25 in all non-O157 *E. coli* strains were calculated as *m/z* 10138.6 and 10694.4, respectively. They are completely equal to that of group C to P shown in [Table 3](#pone-0113458-t003){ref-type="table"}, namely 'non-O157 group', indicating the database constructed in this study will work well for screening of O157 from various types of serovars.

On the other hand, the specific biomarker, H-NS (*m/z* 15425.4 \[M+H\]^+^) for O26 and O111 were observed in another few strains, O118 (strain 08-3651, 06-3612, 06-3256, 2009C-4446, 07-4255), O69 (strain 07-4281, 06-3325, 08-4661, 2009C-3601, 07-3763), O123 (strain 2009C-3307) and O103 (strain 2010C-3214). As they may be classified into the same group with O26 and O111 in our discrimination system using H-NS as biomarker, the extra biomarkers will be required for more detailed identification. Nevertheless it is promising that candidates for serovar O26 and O111 could be found in our system.

The major EHEC serovars O157, O26 and O111 present a great risk for human life, and therefore not only will the rapid discrimination of this strain from other *E. coli* strains aid diagnostics, but it is also vital in ensuring clinical security and food safety. We propose a possible strategy for the effective discrimination of strains O157, O26 and O111 using specific four biomarkers by MALDI-TOF MS as shown in [Fig. 3](#pone-0113458-g003){ref-type="fig"}. Our *S10*-GERMS-based discrimination method uses the arbitrary selected masses of established biomarkers that are confirmed from the approaches of both genomics and proteomics. For automated processing and clustering of the data generated by MALDI-TOF MS, the analytical software 'Strain Solution' (Shimadzu, Kyoto, Japan) could be employed to realize the *S10*-GERMS approach. Our discrimination method will be an important screening tool clinically and in the dairy industry to ensure food safety.

![Strategy for distinguishing between *E. coli* strains O157, O26, O111 and the others using four biomarker peaks in MALDI-TOF MS.](pone.0113458.g003){#pone-0113458-g003}
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